With 0.56 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.31 million shares. During the session, the Banks – Regional company that operates in wider Financial sector, reached to the highest price of $111.95 whereas the lowest price it dropped to was $102.1001. The 52-week range on BMA shows that it touched its highest point at $118.42 and its lowest point at $22.95 during that stretch. It currently has a 1-year price target of $133.45. With its current market cap of 6.56 billion, BMA has annualized dividend of $5.30 while the current yield stands at 5.08%. BMA paid its most recent dividend on 1723766400, while the ex-dividend date for that was 1723766400. Beta for the stock currently stands at 1.69.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of BMA was down-trending over the past week, with a drop of -8.25%, but this was down by -2.23% over a month. Three-month performance surged to 48.60% while six-month performance rose 111.24%. The stock gained 317.19% in the past year, while it has gained 7.95% so far this year. A look at the trailing 12-month EPS for BMA yields 20.54 with Next year EPS estimates of 11.99. For the next quarter, that number is 2.36. This implies an EPS growth rate of -54.10% for this year and 139.64% for next year.
Float and Shares Shorts:
At present, 62.82 million BMA shares are outstanding with a float of 62.81 million shares on hand for trading. On 2024-11-15, short shares totaled 0.63 million, which was 100.0 higher than short shares on 1728950400. In addition to Mr. Jorge Francisco Scarinci C.F.A. as the firm’s CFO, Finance Manager & IR Manager, Mr. Gerardo Adrian Alvarez serves as its Operations & Compliance Manager.
Institutional Ownership:
Through their ownership of 0.11051 of BMA’s outstanding shares, institutional investors have minority control over the company.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for BMA since 1 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 1 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With BMA analysts setting a high price target of 157.0328 and a low target of 14.920321, the average target price over the next 12 months is 89.30034. Based on these targets, BMA could surge 50.34% to reach the target high and fall by -85.72% to reach the target low. Reaching the average price target will result in a decline of -14.5% from current levels.
Analysts have provided yearly estimates in a range of $6831.46659 being high and $4131.94632 being low. For BMA, this leads to a yearly average estimate of $5155.41677. Based on analyst estimates, the high estimate for the next quarter is $2315.85 and the low estimate is $2315.85. The average estimate for the next quarter is thus $2315.85.
